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The energy metabolism of the failing heart is characterised by a 30% decrease of the total adenine nucleotides content and what may be more
important by a 60% loss of creatine and creatine phosphate [J.S. Ingwall, R.G. Weiss, Is the failing heart energy starved? On using chemical
energy to support cardiac function, Circ. Res. 95 (2004) 35–145]. Besides the effect of these changes on the energy supply, failing heart is known
to be more vulnerable to Ca2+ overload and apoptosis-inducing processes. Recent studies have pointed to the critical role of mitochondrial contact
sites in controlling both the mitochondrial energy metabolism and Ca2+ homeostasis. This review focuses on the structure and function of protein
complexes in mitochondrial contact sites and their regulatory role in the cellular bioenergetics, intra- and extra-mitochondrial Ca2+ levels, and
release of apoptosis-inducing factors. Firstly, we review the compositions of different contact sites following by the discussion of experimental
data obtained with isolated and reconstituted voltage-dependent anion channel–adenine nucleotide translocase complexes and consequences of
the complex disassembling. Furthermore, we describe experiments involving the complex-stabilizing conditions in vitro and in intact cells. At the
end, we discuss unsolved problems and opportunities for clinical application of the complex-stabilizing factors.
D 2005 Elsevier B.V. All rights reserved.Keywords: Adenine nucleotide translocator (ANT); Voltage-dependent anion channel (VDAC); Hexokinase; Creatine kinase; Permeability transition pore; Protein
kinase A; Protein kinase B; AMP Kinase; Chronic heart failure1. Introduction
Two ATP regenerating systems exist in the cells that have to
be adapted according to the cellular needs. These are the
phosphorylation of ADP using the high-energy intermediates
generated in the glycolytic pathway, and oxidative phosphory-
lation in mitochondria proceeding by the proton motive force.
Besides the coordination of these two processes, the total ATP
turnover of the cells has to match closely for the actual re-
quirements during growth and differentiation, as well as during
activation and performance of different cellular functions. The
free energy, DG of the ATP hydrolysis depends mainly on the
ATP/ADP ratio. In tissues with high-energy turnover, this ratio is
maintained amazingly stable. For example, in the heart muscle, it
is practically independent on the workload, i.e. on the ATP
turnover [1]. Besides a stable ATP/ADP ratio, the DG of ATP is
always at a very high level of about 59 kJ/mole. We shall present0925-4439/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
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creatine kinase and the adenine nucleotide translocator (ANT)
can contribute to the stability and high DG of ATP.
The hypothesis discussed in this article proposes a central role
of the ANT that forms complexes with specific regulatory
proteins and thus generates contact sites between the mitochon-
drial inner and outer membranes. By this interaction, ANT will
be able to integrate the information on substrate availability,
ATP turnover, and Ca2+ level, to adjust mitochondrial function
accordingly. Moreover, we postulate that ANT through its
regulatory partners becomes the target of hormonal control
mediated by protein kinases A and B as well as AMP-kinase.
2. Molecular structure of mitochondrial contact sites
It has been noticed that contact sites are dynamic structures
[2]. The structure of contact sites is variable and their numbers
are increased in the presence of ADP or atractyloside [3]. Based
on these results, we assume that contacts may be formed by
specific interaction of inner and outer membrane components1762 (2006) 148 – 163
http://www
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Indeed, isolated VDAC and ANT can form complexes in vitro
[4]. But more interestingly, the VDAC–ANT assemble is co-
purified with other mitochondrial proteins. Hexokinase [5] as
well as mitochondrial benzodiazepine receptor [6] were co-
purified with VDAC–ANT forming complex from a Triton
X100 extract of mitochondrial membranes. VDAC and ANT
were also detected in an immuno-precipitation with Bax-specific
antibodies in cells over-expressing Bax [7] and among the
proteins in the extract of mitochondrial membranes other than
cyclophilin D with immobilized anti cyclophilin antibodies [8].
3. Isolation and characterization of VDAC–ANTcomplexes
As mentioned above, VDAC–ANT aggregates could be
isolated from TritonX-100-dissolved brain or kidney mem-
branes by specific interaction of the bound hexokinase with an
anion exchanger. It was found that the bound hexokinase com-Fig. 1. Different configurations of the VDAC–ANT complex connected to either
ANT–kinase complexes can exist in different configurations that either support or
induced by atractyloside) is facing the cytosol and interacts with the outer me
membrane when it interacts with the ANT-c. Hexokinase (HK) associates to tetr
complex. The oligomerization of hexokinase leads to activation of the enzyme. (B
interact with VDAC. VDAC-r (relaxed) is not bound to the ANT and may be pres
VDAC beyond the contacts with less affinity and activity. The dark green squa
membrane correlated to the ANT structure. The active ANT is a dimer and form
separately. (D) A third structure of VDAC, unable to bind hexokinase, is present in
to VDAC as octamer. The octamer preferentially associates with cardiolipin th
transgenic and WT mouse liver mitochondria in situ. Scale bar, 200 nm. (F) Th
calculated from 20 randomly chosen mitochondrial sections in each group. The dif
statistically significant ( P <0.0005 as assessed by ANOVA). Results are means
isolated, digitonin-treated brain mitochondria (200 Ag digitonin/mg mitochondrial
kinase, followed by protein A-gold particles of 6 nm size was used for immuno
already starts to disintegrate. Swollen mitochondria without visible outer membr
membrane whereas the outer membrane (OM) is free of gold grains. Remarkably,
vesicles (arrowheads) or small patches. It is striking that creatine kinase is o
membrane. Fig. A–D are modified versions of figures published in [126], Fig. E,
published in [18].plex contained VDAC and ANT isoform I [5]. Another complex
has been extracted from the same preparation composed of
VDAC, creatine kinase, and ANT [5,9,10]. Based on the
separation and purification of the different complexes, two
types of VDAC–ANT aggregates could be defined: one
complex where VDAC and ANT interacted directly thus
providing VDAC with higher affinity for hexokinase (Fig. 1A)
and a second complex where VDAC interacted indirectly with
the ANT but through mitochondrial creatine kinase octamer. In
this case, VDAC apparently exposes a different structural motif
at the cytosolic side that provided lower affinity for hexokinase
(Fig. 1D) resulting in the fact that hexokinase activity was
always absent in the complexes containing creatine kinase. Free
VDAC in the outer membrane forms dimers [11] (Fig. 1B). This
VDAC structure has lower hexokinase binding capacity.
VDAC–ANT complexes may also exist alone without any
kinase bound (Fig. 1C). Two of these complexes may join
together when hexokinase associates into tetramers by bindinghexokinase or creatine kinase. Each of the three components of the VDAC–
restrain complex formation. (A) The adenine nucleotide translocator (ANT-c,
mbrane pore (VDAC). VDAC-t (tense) may form a tetramer in the outer
amers [12] preferentially in the contact sites formed by the VDAC–ANT-c
) ANT-m (induced by bongkrekate) is orientated to the matrix and does not
ent in the outer membrane as dimer [11,50]. Monomers of hexokinase bind to
res represent cardiolipin that might move from outer to inner leaflet of the
s tetramers in the inner membrane. (C) VDAC–ANT complexes may exist
the complex with the octamer of creatine kinase (CK). Creatine kinase binds
at is bound to the ANT. (E) Transmission electron micrograph (TEM) of
e number of contact sites was divided by the mitochondrial circumference,
ference in the number of contact sites between transgenic and WT mice were
T S.E.M. (G) Pre-embedding labeling of mitochondrial creatine kinase in
protein). A polyclonal rabbit antiserum against brain mitochondrial creatine
localization. Mitochondria are labeled in regions where the outer membrane
ane or with only parts of it are densely labeled on the free accessible inner
the outer membrane remains attached to the inner membrane either forming
ften located (arrowheads) between outer membrane vesicles and the inner
F was modified according to that published in [17], Fig. G is part of a figure
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This is in agreement with the molecular weight determination of
the isolated complexes [5,9,10]. Hexokinase is active as a
monomer of MW 100 kDa, whereas the functionally active
mitochondrial creatine kinase unit is a dimer with MW 85 kDa.
Four dimers of mitochondrial creatine kinase form a cubic
structure with identical top and bottom faces that were able to
connect two membranes [13]. It was observed by in vitro studies
with the isolated proteins that the octamer of mitochondrial
creatine kinase interacts directly with the outer membrane pore
[14,15], while the interaction with ANTmay be indirect through
cardiolipin [15] that is known to be tightly bound to ANT [16]
(Fig. 1D).
Besides functional coupling of activities, the complex
formation has also structural characteristics. This was recentlyshown by using liver mitochondria isolated from transgenic
mice, which, unlike control animals, express mitochondrial
creatine kinase in the liver [17]. It was found that the enzymewas
associated with the mitochondrial membranes and the number of
contact sites increased 3-fold compared with that observed in
control mitochondria (Fig. 1E, F). Furthermore, creatine kinase-
containing mitochondria were more resistant to detergent-
induced (Triton X-100) lysis than wild-type mitochondria. This
observation agrees with the fact that the complexes described
above were not dissociating in Triton X-100 extracts. Mito-
chondrial creatine kinase was localized abundantly in brain
mitochondria, which contain a significant number of contact
sites. Fig. 1G shows that the immuno-gold particles specific for
mitochondrial creatine kinase were found between inner
membrane and attached vesicles of outer membrane [18]. It
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found in the intra-cristae spaces. This was demonstrated by post-
embedding staining with specific antibodies where the enzyme
in the cristae became accessible to the antibodies [18]. In
agreement with this observation, a second group of ANTcreatine
kinase complexes without VDAC could be isolated [9].
4. Reconstitution of functionally coupled VDAC–ANT
complexes
The hexokinase–VDAC–ANT complex and the VDAC–
creatine kinase–ANT complex were isolated and reconstituted
into the vesicles [5,10]. ATP loaded into these vesicles does not
leak out although VDAC is a component of the complexes.
However, the kinases in the complexes have an access to the
internal ATP apparently through ANT. This was shown by either
glucose-6-phosphate formation from external glucose via
hexokinase or creatine phosphate generation by creatine kinase
from external creatine (Fig. 2E, F). Both reactions are inhibited
by atractyloside, a specific inhibitor of ANT. These results
suggest that hexokinase as well as creatine kinase, after
reconstitution, are functionally coupled to ANT. In this
ensemble, ANT is controlling the exchange of adenine nucleo-
tides through VDAC and functioning as an anti-porter [19].
5. Importance of metabolic channeling in regulation of
energy metabolism
The tight, functional coupling of peripheral kinases to ANT
is important for two reasons: firstly, it regulates the activity of
oxidative phosphorylation by ADP supply and secondly, itFig. 2. ANT in complex with VDAC as an anti-porter or uni-porter resembles functio
VDAC–ANT complex in the contact sites of mitochondria. Hexokinase (HK) binds
uni- and anti-porter in a complex with VDAC. The conversion between the two state
arrangement of a complex between VDAC, the octamer of mitochondrial creatine
cardiolipin encircling ANT (dark green squares). It can dissociate to dimers. The d
octamer. Cytochrome c (red circles) binds to cardiolipin and is arranged in the VDA
NADH oxido-reductase activity of VDAC [54]. The cytochrome c in the VDAC–AN
of p53. Bax binds as well to cardiolipin and by that releases cytochrome c. Protein
VDAC–ANT association in the complex. (E) Reconstitution of HK–VDAC–ANT
with different amount of ATP and incubated for 1–20 min at room temperature with
0.1 mM atractyloside. The reaction was terminated by addition of perchloric acid and
dependence of glucose-6-phosphate formation from external glucose. Two different
concentrations were analyzed. The glucose-6-phosphate production was significantly
of VDAC–creatine kinase–ANT complexes from brain tissue in phospholipid vesicl
20 min at room temperature with 5 mM creatine, 10 mM MgCl2, and 0.1 mM ADP i
by addition of perchloric acid and creatine was determined in the supernatant. The gr
creatine. The different complex preparations (filled and open symbols) with diffe
production was completely inhibited by 0.1 mM atractyloside (Atr) in all experiment
of brain membranes and were reconstituted in phospholipid vesicles that were loaded
extracted from the complex with phosphate buffer, pH 4.5. The enclosed malate was
was inhibited either by cyclophilin extraction (Cyp D) or by incubation of the ves
According to Brustovetsky and Klingenberg [33] Ca2+ interacts with the cardiolipin
porter to unspecific uni-porter state. The uni-porter state of the ANT may act as per
from a Triton X 100 extract of brain membranes and was reconstituted in egg yolk ph
by increasing Ca2+ concentrations (Octamer). When the octamer was dissociated i
creatine, 50 mM KNO3, and 4 mM ADP, VDAC–ANT complexes could be form
permeability transition pore and the enclosed malate was liberated (Dimer). The
incubation of the vesicles with 100 nM cyclosporine A (dimer+CSA). The octamer d
reactive oxygen species (shown in D). The figure was modified according to that pincreases the free energy (DG) in the ATP system. To
explicate the first point, we may imagine the situation after
eating a carbohydrate rich meal, glucose in a high concentra-
tion enters the resting muscle cell that should be phosphor-
ylated and converted into UDP-glucose to accomplish
incorporation into glycogen. The ATP for this process is more
efficiently provided by oxidation of pyruvate in mitochondria
rather than from its conversion into lactate. The oxidative
pathway is induced by hexokinase bound to the VDAC–ANT
complex. The enzyme catalyses glucose phosphorylation at the
expenses of intra-mitochondrial ATP and thus, activates
oxidative phosphorylation. To describe the second advantage
of metabolic channeling, we have to consider that all ATP
energy-consuming processes in the cell (including ion pumps)
depend on the transfer of the g phosphoryl group of ATP
according to the reaction:
ATPþ X ¼ X  P þ ADP ð1Þ
In a subsequent step, X –P dissociates when, for example, the
ion is pumped. This means the efficiency of ATP to drive
these phosphorylation reactions depends on the level of ADP
and Pi during the reaction according to the equation of:
DG ¼  DGo þ RT ln ADP½  Pi½ = ATP½  ð2Þ
Thus, the free energy (DG) of ATP for transferring a
phosphoryl group in ATP-dependent reactions would increase,
if ADP and Pi would be low or be continuously withdrawn
from the reaction. In the complex between mitochondrial
creatine kinase and the ANT, these requirements are perfectly
fulfilled. The equilibrium of the reaction will never be reached;
as the just exported ATP is directly utilized and produced ADPnally the permeability transition pore. (A) The arrangement of the hexokinase–
as a tetramer to the VDAC–ANT complex. (B and C) The two states of ANT as
s is regulated by Ca2+ binding to cyclophilin (blue pentagon). (D) The possible
kinase and ANT in the contact sites of mitochondria. The octamer binds to
imer can be nitrated by peroxynitrite (ROS). This hinders re-association to the
C–ANT complex close to VDAC [50]. It may act as electron acceptor of the
T complex is the preferred target of Bax (blue ellipse) induced under the regime
kinase B (PKB) counteracts this process by increasing hexokinase binding and
complexes from brain tissue in phospholipid vesicles. The vesicles were loaded
5 mM glucose, 10 mM MgCl2, and 0.1 mM ADP in the presence or absence of
glucose-6-phosphate was determined in the supernatant. The graph shows time
complex preparations (filled and open circles) with 15 or 21 AM internal ATP
inhibited by 0.1 mM atractyloside (filled and open triangles). (F) Reconstitution
es. The vesicles were loaded with different amount of ATP and incubated for 1–
n the presence or absence of 0.1 mM atractyloside. The reaction was terminated
aph shows time dependence of creatine phosphate (CrP) formation from external
rent (AM) internal ATP concentration were analyzed. The creatine phosphate
s (filled triangles). (G) The complexes were isolated from a Triton X-100 extract
with malate or ATP. Cyclophilin was co-purified with the complex and could be
released from the vesicles by Ca2+ between 100 and 600 AM. The malate release
icles with 0.5 AM cyclosporine A (CSA) after addition of 200 or 500 AM Ca2+.
around the ANT thus changing the structure of the ANT from ATP/ADP anti-
meability transition pore in intact mitochondria. (H) The complex was isolated
ospholipid liposomes that were loaded with malate. The malate was not released
nto dimer by 20 min incubation of the liposomes with 5 mM MgCl2, 20 mM
ed. In these complexes, Ca2+ could shift the ANT structure to the unspecific
malate permeability of the permeability transition pore was inhibited by pre-
imer equilibrium of the mitochondrial creatine kinase can be shifted to dimer by
ublished in [126].
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excluded through complex formation. Thus, metabolic chan-
neling by functional coupling between ANT and creatine
kinase drives the balance of the reaction between creatine and
ATP far towards the creatine phosphate production. A further
advantage of this coupling to ANT is that the higher free
energy of ATP at the surface of the inner membrane is
conserved as a higher creatine phosphate/creatine ratio. ATP is
electrogenically exported by the ANT at the expenses of the
membrane potential. It has been calculated that this process
increases the free energy of ATP by an additional 12 kJ/mol
[20]. This would also contribute to increase the creatine
phosphate/creatine ratio through coupling between mitochon-
drial creatine kinase and ANT. Recent evidence for direct
coupling between mitochondrial creatine kinase to intra-
mitochondrial ATP comes from in vivo 31P-NMR studies
showing creatine phosphate re-synthesis coupled to mitochon-
drial respiration in humans [21], as well as from respiratory
measurements with skinned fibers from wild type and
transgenic mice lacking mitochondrial creatine kinase [22].
Furthermore, creatine phosphate generation in isolated respir-
ing mitochondria without external nucleotides was shown,
suggesting a recycling of an internal pool of adenine
nucleotides via mitochondrial creatine kinase [23]. The ability
of the heart to increase cardiac performance in response to
demands is significantly reduced in chronic heart failure. This
is mainly due to the decreased phospho-transferase activity of
the creatine kinase system in the patients [24]. One significant
consequence of the creatine kinase inhibition was a decreased
free energy DG in the ATP system [25], which emphasizes the
importance of metabolic channeling, and creatine phosphate
production in building up high mitochondrial derived free
energy.
6. The VDAC–ANT complex as a permeability transition
pore
Mitochondria contain a structure that in vitro forms a large
unspecific pore under conditions of high matrix Ca2+, Pi and
oxidative stress [26]. Opening of this, so-called permeability
transition pore was fully reversible upon withdrawing Ca2+ [27].
Electrophysiological measurements revealed properties of the
pore related to VDAC suggesting that it may be a component of
the whole structure [28,29]. The permeability transition pore in
most cases could be specifically blocked by cyclosporine A,
which apparently binds to cyclophilin D present in the
mitochondrial matrix [30]. By employing a cyclophilin D
affinity matrix, a complex between VDAC and ANT was
isolated by Crompton et al. from a CHAPS extract of heart
mitochondrial membranes [8]. This complex when reconstituted
into the vesicles was functioning as a pore induced by Ca2+ and
Pi which was blocked by cyclosporine A. Comparable results
were obtained with the isolated hexokinase VDAC–ANT
complex. Cyclophilin was co-purified with other components
of the complex [9,10]. The complex was reconstituted into
phospholipid vesicles that were loaded with malate. The internal
malate was released upon increasing Ca2+ concentrations. Theprocess was inhibited by cyclosporine A suggesting that the
reconstituted hexokinase VDAC–ANT complex had properties
of the permeability transition pore (Fig. 2G). Two questions are
worthy of discussion: firstly, whether ANT is the only structure
that causes permeability transition and secondly whether ANT
forms the pore only being within a complex with VDAC. As to
the first question, it is assumed that all related anti-porters in the
inner membrane such as Pi/OH- or Glut/Asp exchanger can form
a permeability transition pore depending on the actual condition
[31]. This would explain the recent results of Kokoszka et al. in
mouse liver with genetically inactivated two ANT isotypes,
where cyclosporine A-sensitive mitochondrial permeability
transition was still observed [32]. As to the second question, it
is to say that purified ANT also forms unspecific pores in the
presence of high Ca2+. This was shown by reconstitution into
planar bilayer membranes [33] or into vesicles [34]. Yet these
pores were not sensitive to cyclosporine A as cyclophilin D was
missing. Cyclophilin D was considered as an obligatory
regulatory component of the permeability transition pore [30]
although recent data from Bernardi group and later from other
labs demonstrated the induction of the transition pore in
cyclophilin D knockout mice [35–38] (caused by much higher
Ca2+ than that needed to induce the pore in mitochondria of wild
type mice). This at the first glance requires a revision of the
existing dogma. However, the clue may be that the pore is still
Ca2+ sensitive but its Ca2+ dependence is shifted towards higher
Ca2+ concentrations. It also should be mentioned that Ca2+
dependence of the mitochondrial pore is absent in situ in cardiac
myocytes where it has been induced by reactive oxygen species,
generated by the light to excite fluorescent indicators [39]. This
Ca2+ dependence of opening of mitochondrial transition pore,
absent in intact cells, is however, present in permeabilized cells
and isolated mitochondria [40], supplementary data], showing
that the phenomenon is more complex than it is seen now.
7. The conversion of ANT into unspecific uni-porter is
controlled by the oligomeric state of the creatine kinase
The idea that VDAC may have as well regulatory influence
on ANT was supported by the analysis of the reconstituted
VDAC–creatine kinase–ANT complex. In contrast to the
reconstituted hexokinase complex, malate that was enclosed in
the vesicles containing creatine kinase complex, was not
released by addition of Ca2+ (Fig. 2H). As shown schematically
in Fig. 2D, VDAC is linked to the octamer of creatine kinase
that hinders a direct contact with ANT. However, direct
interaction between VDAC and ANT was possible after
dissociation of the creatine kinase octamer. In this case, malate
was liberated from vesicles upon Ca2+ addition (Fig. 2H). The
release was inhibited by cyclosporine A. These results
suggested that VDAC may have a regulatory function on
ANT. Such regulation by VDAC keeps the ANT in the c
conformation and exposes the ATP/ADP binding site to the
cytosolic surface of the inner membrane, according to the re-
orientating carrier model proposed by Klingenberg et al. [41].
This conformation of the ANT is induced by atractyloside and
facilitates Ca2+-dependent opening of the permeability transi-
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octamer of mitochondrial creatine kinase, ANT conversion into
a permeability transition pore would be suppressed (Fig. 2H).
In fact, this has been observed in a transgenic mouse model
expressing creatine kinase in liver mitochondria, which
normally is absent in liver [17,23,42]. The permeability
transition pore is known to be induced by atractyloside and
Ca2+ in normal liver mitochondria. In contrast, in liver
mitochondria from transgenic mice containing creatine kinase,
the permeability transition was inhibited by substrates that
stabilized the octamer of creatine kinase such as creatine and
cyclo-creatine. The results showed that the ANT structure and
its Ca2+ sensitivity are influenced by interaction with the
creatine kinase octamer. On the other side, VDAC structure
also changes depending on the interacting partner: either
creatine kinase octamer or just ANT.
8. The VDAC structure and function in the ANT complex
No direct information about the structure of VDAC in the
ANT complex is available. However, it was observed that the
VDAC properties (permeability and ability to bind hexokinase)
are changed as soon as interaction between VDAC and ANT
occurs to form a contact site. This gives strong evidence on
different structures of VDAC at the mitochondrial surface.
Isolated VDAC, when reconstituted into artificial bilayer
membranes, shows voltage dependence of the conductance
[43,44]. At a voltage smaller than 30 mV, the pore has an
effective diameter about 4 nm and the channel has a slight
anionic selectivity and high conductance (4 nS at 1 M KCl in
the bathing medium). Above 30 mV, the diameter of the pore is
reduced to 2 nm and conductance decreases to 2 nS with ion
selectivity shifted to cations. The voltage-dependent conduc-
tance variations are certainly linked to structural modification
of VDAC. So far, no information about the nature of these
changes is available. It has been postulated that a positively
charged loop moves out of the channel [45] but it is also
possible that negative charges move into the gate of the
channel. Macromolecules such as dextran, that cannot enter the
pore, have an osmotic effect on the aqueous interior of the
channel [46] thus increasing the steepness of the voltage
dependence. In the presence of dextran, the low conductance
cation selective state is adopted already at 10 mV [47]. It has
been postulated that VDAC acquires this low conductance state
in the contact sites where the inner membrane potential extends
to the outer membrane by capacitive coupling [48]. Recently, a
new idea of generation of a potential at the outer membrane
was proposed coupled to the metabolic cycling and transloca-
tion of negative charges in ATP, ADP, and Pi across the inner
membrane [49]. On the whole, indirect evidence suggests that
VDAC in the outer membrane exists in different functional
states (Figs. 1 and 2). In support of this, it was recently
observed by cross-linking that VDAC was present as tetramer
and dimer in the outer membrane of isolated mitochondria [50].
On one hand, upon interaction with ANT, VDAC may adopt a
structure that is comparable to the low conductance state
observed in bilayer membranes. We define it as a tense stateand a possible property of the tetramer (Fig. 1A, C). On the
other hand, VDAC being free (Fig. 1B) or bound to creatine
kinase (Fig. 1D) may adopt the structure of a dimer comparable
with the high conductance state that is here defined as relaxed
state. In these two diverse states, VDAC apparently reveals a
different structure at the outer membrane surface. This has
important regulatory implications as only tense VDAC has
high capacity of hexokinase binding (Fig. 1A, VDAC-t) [51].
Moreover, as will be described below VDAC-t is also the
preferred target for Bax and generates a specific residence for
cytochrome c at the mitochondrial periphery. Our definition of
the different functional states of VDAC in the outer membrane
has got support from the recent studies where it was described
that interaction with hexokinase led to a reduction of
conductance of VDAC reconstituted in bilayer membranes
[52]. Hashimoto and Wilson have analyzed different epitops at
the surface of bound hexokinase by specific monoclonal
antibodies and observed a variation of the bound hexokinase
structure that correlated with functional changes of oxidative
phosphorylation in the inner membrane [53]. This direct
reflection of inner membrane functions at the hexokinase
surface strongly supports complex formation between VDAC
in the outer and ANT in the inner mitochondrial membranes.
In addition to its function as a pore in the outer membrane, it
has also been recently shown that VDAC can function as an
NADH dehydrogenase at the plasma membrane [54]. Given the
known regulatory roles of NADH in the permeability transition
pore [55], it will be interesting to see if these effects are
mediated in part via NADH-induced changes in VDAC
structure, which may affect its formation of contact sites and
related complexes.
9. Physiological significance of the voltage dependence
VDAC in the low conductance cation selective state is not
permeable for ATP, ADP and other negatively charged small
molecules. This has been demonstrated in Colombini’s
laboratory when investigating VDAC reconstituted into
artificial membranes [56]. In isolated mitochondria, in the
compartment between outer and inner membrane enzymes
such as adenylate kinase have no access to external adenine
nucleotides in the presence of Ko¨nigs polyanion [57] that
causes transition of VDAC into its low conductance state [58].
By conveying these results to the physiological situation,
where more contact sites are formed and macromolecules are
present, we have to assume most of VDAC in the low
conductance and thus cation selective state. Indeed, mitochon-
dria in situ in permeabilized cardiomyocytes and skinned red
muscle fibers had 10 times higher apparent Km for ADP as
compared to isolated mitochondria from the same tissue. The
high Km could be reduced to values of isolated mitochondria
by permeabilizing the outer membrane with digitonin or Bax
suggesting that in situ the outer membrane was not freely
permeable for ADP [59]. Besides pure voltage-dependent
regulation, specific proteins have been described that physi-
ologically may contribute to the regulation of the VDAC
permeability [60,61].
Fig. 3. Influence of adenine nucleotide translocator (ANT) inhibitors on
distribution of hexokinase, creatine kinase and cytochrome c in sub
fractionations of mitochondrial membranes. Kidney mitochondria pretreated
as described below were disrupted by osmotic shock and the fragments were
separated by sucrose density gradient (54.3%, left –30.8%, right) centrifuga
tion. The graphs show activity of enzymes in the different gradient fractions
SDH—succinate dehydrogenase (dashed line), CK—creatine kinase (red line)
HK—hexokinase (black line), Cyt C—cytochrome c (white circles). (A
Distribution of enzymes after pre-incubation mitochondria with 1 mM
atractyloside. (B) Hexokinase and creatine kinase distribution in contact sites
and in cristae upon treatment of mitochondria with 1 mM bongkrekic acid. (C
Distribution of the enzymes and cytochrome c in mitochondrial sub-fractions o
untreated mitochondria. The experiments shown in this figure were published
in reference [70].
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There are several signal- and tissue-specific pathways to
induce apoptosis. One element of such a pathway is a release
of cytochrome c from mitochondria [62,63] that activates
caspases [64] by binding to a cytoplasmic protein Apaf-1 in
the presence of dATP [65]. The mechanism by which external
Bax releases cytochrome c is still controversial and may also
depend on the actual localization of cytochrome c and on the
binding and incorporation of Bax into the outer mitochondrial
membrane. VDAC and ANT interact solely when adopting a
specific molecular conformation. The ANT must be in c-
conformation as atractyloside induces the complex with the
outer membrane pore [3], while bongkrekate is shifting the
ANT to the matrix-orientated m-conformation [41] thus
repressing this interaction. VDAC in a complex with ANT
appears to be in the low conductance cationic selective state
that is here defined as the tense state in contrast to the high
conductance state which is called as relaxed state (Fig. 1A,
B). The existence of various VDAC properties in situ can be
deduced from the observation that heart muscle mitochondria
in cardiomyocytes show a reduced response to external ADP
[59]. The structural change of the outer membrane pore after
its interaction with ANT is recognized at the mitochondrial
surface and leads to higher capacity of hexokinase binding
[51]. Recent findings suggest that this tense pore structure is
the preferred target for Bax molecules (Fig. 2C). Pastorino et
al. [66] found that hexokinase and Bax compete for the same
binding site and Capano and Crompton [7] were able to
detect VDAC and ANT after immune precipitation with anti
Bax antibodies in extracts from cardiomyocytes.
11. Cytochrome c distribution at the mitochondrial
periphery depends on the formation of contact sites
We analyzed the distribution of cytochrome c, hexokinase,
and creatine kinase in sub-fractions of kidney mitochondria
obtained by osmotic shock and subsequent sucrose density
centrifugation. This method leads to a separation of contact
sites from inner membrane fragments and unbroken mitochon-
dria. The contact site fraction is characterized by high
hexokinase activity, whereas succinate dehydrogenase (SDH)
is representative for all fractions containing inner membrane
[67] (Fig. 3C). At low ionic strength, cytochrome c is not
released from the membranes. Thus, in sucrose-based medium
used here, even after rupture of the mitochondrial membranes
cytochrome c remained bound at the sites as before disruption
of the organelles. So far, most investigators have not
considered compartmentalization of cytochrome c within the
inner mitochondrial membrane. It is generally agreed that
cytochrome c is bound to the outer surface of the inner
membrane but little is known about its distribution along this
surface, i.e., its specific location in the peripheral inner
membrane, cristae membrane, and contact sites. As depicted
in Fig. 3C, it was found that the contact site fraction contained
about 25% of cytochrome c compared to the cristae membrane






fmembrane that contains no F1-ATPase and almost no
cytochrome oxidase. It was assumed that this cytochrome c
might be associated with the contact sites (Fig. 2A, D). Indeed,
as described below, cytochrome c co-migrated on a DEAE
cellulose column with the hexokinase–VDAC–ANT and the
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rat brain and kidney membranes [5,9].
Based on the results described above, we concluded that a
specific component of the contact site-forming complexes might
be responsible for cytochrome c and creatine kinase binding.
Considering that cytochrome c and creatine kinase bind
specifically to cardiolipin that embraces ANT [16], we studied
their distribution under conditions that changed the structure of
ANT from c- (atractyloside) to m- (bongkrekate) conformation.
We expected to obtain some changes in cardiolipin distribution
related to the change of ANT conformation.
Contact sites of kidney mitochondria were prepared and
separated as described above. Atractyloside known to induce
contact sites [3] resulted in increased hexokinase and creatine
kinase activity and in parallel a higher cytochrome c content in
a contact site fraction (Fig. 3A). At the same time, pre-
incubation with bongkrekate, that dissociates VDAC–ANT
complexes, leads to a decrease of hexokinase and creatine
kinase activity and also of cytochrome c content in the contacts
(Fig. 3B). With bongkrekate, the activity of creatine kinase
(which is shifted towards the cristae) is latent. Full activity of
this enzyme is elicited after dissolving the membranes by
detergent. By employing different cross-linking reagents, it was
recently shown that VDAC exists as a dimer or tetramer in
intact mitochondria or when reconstituted in vesicles. In
agreement with our assumption of VDAC oligomerization in
the contact sites (Figs. 1, 2), it was observed that especially
VDAC oligomers bind cytochrome c [50]. In general, the
results show that cytochrome c distribution inside mitochondria
is variable. It can be assumed that this has a large effect on its
release. Scorrano et al. [68] found that the ‘‘BH3-only’’
molecule tBID induces a striking remodeling of mitochondrial
structure with mobilization of the cytochrome c stores (85%) in
cristae. This reorganization releases cytochrome c without
detectable swelling and is independent of BAK, but is inhibited
by cyclosporine A. During this process, individual cristae
become fused and the junctions between the cristae and the
inter-membrane space are opened.
12. The VDAC–ANT complexes contain cytochrome c that
can be released by external Bax
Creatine kinase and hexokinase involved in formation of
different types of contact sites were found in the same
mitochondrial contact site fractions as shown above. By
applying the purification technique employed in Fig. 2,
different types of contact sites forming complexes could be
separated. The differences of surface charge between creatine
kinase and hexokinase led to a separation of the complexes
containing VDAC, ANT and two kinases after dissolving the
brain membranes by Triton X-100 [5,9,10].
The hexokinase–VDAC–ANT complexes contained a sig-
nificant amount of cytochrome c [69,70]. This was found when
the complex was eluted from anion exchanger column by 200
mM KCl suggesting that cytochrome c was not bound by ionic
interaction. To investigate whether Bax would be able to interact
with cytochrome c within the VDAC–ANT complexes, thelatter were reconstituted into phospholipid vesicles schemati-
cally depicted in Fig. 4. After reconstitution, the vesicles were
loaded with malate. Bax liberated the endogenous cytochrome c
but did not release the internal malate (Fig. 4A). However,
malate could be liberated by Ca2+ through the permeability
transition pore. The Bax-dependent liberation of endogenous
cytochrome c was abolished when the VDAC–ANT complex
was dissociated by bongkrekate [69,70] (Fig. 4B).
13. Possible function of cytochrome c in the contact sites
The nature of cytochrome c binding in the contact sites is
not known yet. It can only be speculated that the negatively
charged phospholipid cardiolipin that is associated with ANT
[16] may be the cytochrome c (which is polycation at
physiological pH) docking site (Fig. 2). The cytochrome c
function in porin–ANT complex stays known. Bernardi and
Azzone [71] described an electron transport pathway between
the outer membrane and the peripheral inner membrane in
which cytochrome c was involved. This pathway channels
electrons from external NADH to cytochrome oxidase.
Marzulli et al. [72] observed that oxidation of external NADH
was stimulated by induction of contact sites by atractyloside or
ADP whereas it was suppressed by glycerol known to decrease
the number of contact sites [2]. This electron transport pathway
may involve the cytochrome c fraction located in contact sites
as described here (Figs. 2C and 3). In a recent publication, it
was observed that VDAC-1 itself has NADH:ferricyanide
reductase activity [54]. Thus, VDAC through cytochrome c
bound in the ANT complex may act as a sensor of the NAD/
NADH redox state in the cytosol (Fig. 2C). The electron
pathway involving cytochrome c as described above may
provide a direct electron exchange with cytochrome oxidase in
both directions.
14. The importance of the kinases in regulation of
cytochrome c release and apoptosis
Release of cytochrome c from mitochondria proceeds in
two steps: the first one involves the release of a small fraction
of cytochrome c from the compartment between the outer-
and peripheral inner membranes and the contact sites (Fig. 2).
It is induced by low concentrations of Bax [73] in the early
phase [7]. The second step includes release of additional
fractions of cytochrome c bound to the surface of the cristae
membranes and results from opening of the permeability
transition pore, followed by mitochondrial swelling and
membrane disruption [74]. Opening of permeability transition
pore is induced by high Ca2+ level (see below) that also may
detach cytochrome c from its cardiolipin binding sites. The
massive cytochrome c release can also be a consequence of
VDAC closure preceding membrane disruption [75]. The
observed failure of mitochondria to exchange adenine
nucleotides with the cytosol may be a consequence of the
transformation of VDAC into the tense state. The two
described kinases bound to VDAC are involved in the
regulation of both processes of cytochrome c release.
Fig. 4. Bax-dependent release of cytochrome c from the hexokinase–VDAC–ANT complex. (A) Schematic representation of the reconstituted hexokinase (HK)–
VDAC–ANT complex in multi-layered vesicles. Cytochrome c (circles) that was still attached to the complexes could be released by Bax as shown in the right
panel. However malate, loaded into the vesicles, was not liberated by Bax but by 200–500 AM Ca2+ through opening the ANT as permeability transition pore (Fig.
2G). This suggested that Bax was specifically interacting with the cytochrome c in the VDAC ANT complex. The sigmoid curve of cytochrome c release might
indicate that Bax is accomplishing this process as oligomer. (B) Schematic representation of the association–dissociation of the hexokinase VDAC (P) ANT complex
by atractyloside (ATR) or bongkrekate (BA) after reconstitution in multi-layer vesicles. Treatment of the complexes with bongkrekate changed the ANT into the m-
conformation (ANT-m). This led to dissociation of the complex and a correlated structural change of VDAC, with a decreased affinity for hexokinase and Bax.
Cytochrome c might have redistributed as well. As shown in the right panel Bax was unable to release cytochrome c after the structural change of the complex by
bongkrekate. Entire cytochrome c remained in the sediment (BA sed) in contrast to the control, without bongkrekate treatment, and no cytochrome c appeared in the
supernatant (BA sup). The figure was modified according to that published in [126].
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and permeability transition by hexokinase
Hexokinase binds to the outer membrane pore in its tense
state, i.e., when VDAC interacts with ANT. In this state,
VDAC is not freely permeable for adenine nucleotides. This
state has already been observed in mitochondria in the
presence of dextran that increases hexokinase binding and
contacts between VDAC and ANT [51]. In these mitochon-
dria, external pyruvate kinase has limited access to ADP
generated by bound hexokinase [76]. Although VDAC in its
tense state does not allow passage of ATP, hexokinase utilizes
mitochondrial ATP suggesting a structural modification of
VDAC after kinase binding. As summarized in Fig. 5, theFig. 5. Interactions of mitochondrial Ca2+ with energy supplying enzymes in excitab
turnover leading to the increase of cytosolic creatine through activity of cytosolic
supply by the activity of mitochondrial creatine kinase that is linked to the adenin
complex with CK, the ANT is acting as anti-porter in the inner membrane. (B) In
permeability transition pore (PTP) that releases Ca2+. (C) The mRyR may be linked
may lead to increased ROS formation if it is not accompanied by ADP increase that i
hexokinase complex, the enzyme forms a tetramer that is linked to two dimers of VD
conformation (ANT-c, induced by atractyloside), where it can operate either as anti-p
ANT in the m-conformation (ANT-m, induced by bongkrekate) does not form com
leads to activation of the enzyme. VDAC obtains a different (tense=VDAC-t) struc
bind hexokinase. AMP protein kinase (AMPK) and protein kinase B (PK-B, Akt) s
kinase A (PK-A) and free fatty acids FFA support the desorption of hexokinase from
boundary membrane, CM: cristae membrane, AdK: adenylate kinase, Glut 4: glucoactivity of mitochondrial bound hexokinase was found to be
important for protein kinase B-linked suppression of cyto-
chrome c release and apoptosis [77,78]. The experiments
suggested that following withdraw of growth hormone, Bax
liberated the small fraction of cytochrome c from the contact
sites. In complete agreement with this, the Bax-dependent
release of cytochrome c assembled into VDAC–ANT com-
plexes described above was inhibited by activity of hexoki-
nase in the presence of glucose and ATP [69,70]. This was
explained by stabilization of hexokinase binding to VDAC,
which also is the main target for Bax. Besides this effect on
Bax-dependent cytochrome c release, activation of hexokinase
inhibited Ca2+-dependent opening of the permeability transi-
tion pore by ADP production [5,10].le cells. (A) The biological work (e.g. contraction) triggers cytosolic ADP–ATP
creatine kinase (CK). Creatine causes an increase of intra-mitochondrial ADP
e nucleotide translocator (ANT) through cardiolipin (dark green squares). In a
absence of ADP and presence of high Ca2+, the ANT can form an unspecific
to VDAC. Ca2+ activates substrate supply to the electron transport chain. This
n turn decreases ROS production through activation of ATP synthesis. (D) In the
AC and ANT (not shown, but see Fig. 1). The ANT in this complex is in its c-
orter to exchange ATP for ADP or as uni-porter forming an unspecific pore. The
plexes with VDAC and cannot cause PTP. The oligomerization of hexokinase
ture by interaction with ANT in the c conformation that has higher capacity to
timulate the binding of hexokinase to the VDAC ANT complex, while protein
the mitochondrial membrane OM: outer mitochondrial membrane, IBM: inner
se transporter. The figure was modified according to that published in [126].
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through hexokinase binding to the mitochondrial surface is
AMP kinase (Fig. 5) [79]. The enzyme is activated by
increased AMP levels (for example, under chronic stimulation
of white muscle fibers) and induces enzymes of citric acid
cycle and fatty acid oxidation as well as the glucose
transporter Glut4 in the cell membrane and increases
hexokinase activity at the mitochondrial surface [80,81]. It
was found that activator ICAR-induced stimulation of AMP
kinase suppresses apoptosis [82].
16. Suppression of permeability transition and cytochrome
c release by mitochondrial creatine kinase
Mitochondrial creatine kinase interacts with VDAC
exclusively in the octameric state, while the dimer has only
weak affinity to the pore [14,15]. Thus, the association–
dissociation equilibrium between octamer and dimer deter-
mines the formation of octamer–VDAC complexes. On the
other side, VDAC–ANT complexes or opening of perme-
ability transition pore may be induced by dissociation of the
octamer (Fig. 2D). Besides acting as a lock between VDAC
and ANT to prevent permeability transition the octamer
presence has an influence on number and stability of contact
sites. Liver mitochondria from transgenic mice expressing
ubiquitous mitochondrial creatine kinase in this organ
showed a 3-fold increase in contact sites and increased
resistance against detergent-induced lyses as compared to
controls [17]. These transgenic livers also become largely
tolerant against tumor necrosis factor TNF-a-induced apo-
ptosis [83].
Free radicals can shift the octamer–dimer equilibrium of
the mitochondrial creatine kinase towards dimerization [84].
Especially sarcoplasmic but also ubiquitous mitochondrial
creatine kinases (present in brain and kidney) are highly
susceptible to peroxynitrite treatment in vitro [85], well within
the physiological range [86] (Fig. 2C–D). Since mitochon-
drial creatine kinase inactivation occurs at peroxynitrite
concentrations much below those affecting the respiratory
chain itself, this iso-enzyme is indeed a prime target of
peroxynitrite-induced modification and inactivation [85,87].
Peroxynitrite also leads to a decrease in octamer formation
from dimeric mitochondrial creatine kinase and a dose-
dependent dissociation of octamers into dimers [85,87]. This
might explain why ligation of the coronary artery in guinea
pigs led to a decrease of octamer from 85% to 60% in the
infarcted area of the heart [88] since it is known that
peroxynitrite may play a pathologic role in ischemia–
reperfusion injury. As a consequence of creatine kinase
octamer dissociation, the probability of a direct VDAC–
ANT interaction is increased. The formation of the latter
complexes has two outputs: (1) cytochrome c is rearranged as
shown in Fig. 2A and C and becomes a target for Bax (Fig.
4), and (2) the VDAC–ANT complex provides the conditions
for Ca2+-induced permeability transition (Fig. 2B), followed
by mitochondrial swelling, membrane disruption, cytochrome
c release, and apoptosis.17. The general importance of the creatine kinase system in
heart performance
Several studies with perfused heart suggest that global
creatine kinase inactivation directly affects heart performance
[89–91]. Interestingly, one consequence of ischemic precondi-
tioning, as a cardioprotective tool [92], is a higher flux through
the creatine kinase system and preservation of functional
coupling between mitochondrial creatine kinase and ANT
[93,94]. Decreased activity of kinase at sites of energy
production and utilization may contribute to alterations in
energy fluxes and regulation of calcium homeostasis in heart
failure [95,96]. The study using double knock-out of cytosolic
and mitochondrial creatine kinase in mouse muscle demon-
strated that below a certain level of creatine kinase activity, the
energy expenditure upon cardiac work become less efficient
[97]. In animal models of dilated cardiomyopathy, hypertrophy
and heart failure, the decrease of the creatine kinase–creatine
phosphate system preceded the development of contractile
dysfunction and led to decreased energy reserve [98–100].
18. Regulation of intra-mitochondrial Ca2+ by ADP
supplying kinases: a unified scheme for Ca2+ signalling
and bioenergetics
The mitochondrial metabolism of excitable tissues such as
brain, heart, and skeletal muscle responds not only to rapid
changes in energy turnover but also to large fluctuations of
Ca2+ levels. We try to set up an apparent analogy of the
mitochondrial Ca2+ transport with that of the sarcoplasmic
reticulum. There are data demonstrating that mitochondria
contain, in addition to Ca2+ uniporters (CaUP) and rapid mode
of Ca2+ uptake (RaM), a ryanodine receptor [101] with an
activity dependent on the Ca2+ electrochemical gradients across
mitochondria inner membrane. At the same time, massive
overloading with Ca2+ leads to Ca2+ release from mitochondria
[102] (comparable with reticular Ca2+-induced Ca2+ release). It
has been suggested that transient opening of the permeability
transition pore might specifically reflect this process [103,104],
although of course an open permeability transition pore does
not actively export Ca2+, and can only allow Ca2+ to travel
down its electrochemical gradient. Thus under conditions of a
very negative mitochondrial membrane potential, low mito-
chondrial Ca2+, and high cytosolic Ca2+, it is unlikely that Ca2+
can exit through the permeability transition pore.
Among several related anti-porters in the mitochondrial
inner membrane it is ANT, which can switch between anti-
porter state specific for ATP/ADP exchange and uni-porter
state where it forms an unspecific pore and induces perme-
ability transition [105]. The switch between two functional
ANT states (summarized in Fig. 5) provides the basis to adjust
the mitochondrial function to the actual energy demand. The
same regulatory mechanism is employed by the higher ranking
hormonal control such as by growth factors through protein
kinase B or by epinephrine through c-AMP-dependent protein
kinase A as well as by increased AMP level and AMP kinase.
As depicted in Fig. 5, the end-processor of all mentioned
D.G. Brdiczka et al. / Biochimica et Biophysica Acta 1762 (2006) 148–163 159regulatory pathways could be the ANT-associated protein
complexes in the mitochondrial contact sites.
Moreover, to activate mitochondrial ATP production, intra-
mitochondrial substrate supply and ADP must be increased at
the same time, as unbalanced overproduction of substrate
would lead to ROS formation. Inhibition of Ca2+-dependent
ROS production by stimulation of the oxidative phosphoryla-
tion might be an additional important function of the ADP
supplying kinases [106].
The cellular mechanisms that account for the abrupt
secondary rise of cytosolic Ca2+ during excitotoxicity are still
unclear. In granule neurons, excitotoxic glutamate-induced
Ca2+-dependent mitochondrial permeability transition was
demonstrated [107]. Alano et al. [108] recently showed in
striatal neurons that mitochondrial Ca2+ release was triggered
by the permeability transition pore as it was inhibited by
methyl-valine-cyclosporin A that binds exclusively to the
mitochondrial cyclophylin D. As shown in Fig. 2, mitochon-
drial creatine kinase octamer is part of the permeability
transition pore complex, which couples VDAC from the
mitochondrial outer membrane and ANT from the inner
membrane. The Ca2+-dependent opening of the permeability
transition pore was suppressed by the octamer in the
reconstituted creatine kinase complex (Fig. 2H). In isolated
mitochondria, creatine, and cyclocreatine were as well sup-
pressing permeability transition pore opening apparently by
stabilizing the octamer [23,42]. The same mechanism may
occur in cultured neurons where presence of creatine blocked
apoptosis induced by NMDA receptor activation [109–111]. It
was found that the neurotoxic high cytosolic Ca2+ level
remained unchanged also in the presence of creatine suggesting
that the critical intramitochondrial Ca2+ concentration which
triggers the permeability transition pore could be higher in the
presence of creatine and creatine kinase-dependent ADP
supply [M. Ott and D. Brdiczka et al. unpublished].
19. Conclusions
The mitochondrial inner membrane contains several related
anti-porter proteins. Among these substrate exchangers, ANT is
the most abundant one. It is very essential for this type of
transport proteins that they can be switched between anti-porter
state specific for substrate exchange such as ATP and ADP and
uni-porter state where they become unspecific pores that can be
assigned for permeability transition [105]. This change
between two functional ANT states (summarized in Fig. 5)
provides the basis to adjust the mitochondrial function to the
actual energy demand and regulatory signals such as Ca2+ and
the hormonal control. Increase of cytosolic Ca2+ upon
excitation in muscle and nerve cells leads to uptake into the
mitochondria by the mitochondrial Ca2+ transporters (including
a mitochondrial ryanodine receptor [101]) functionally depen-
dent on the mitochondrial membrane potential. High intra-
mitochondrial Ca2+ concentration and depolarization of mito-
chondrial membrane potential could result in Ca2+-induced
Ca2+ release [102]. It has been suggested that transient opening
of the permeability transition pore might be involved in thisprocess [103,104]. We hypothesize that the VDAC–ANT
complex performs the Ca2+ release when ANT is in its
uniporter state. The change between two states of ANT is
regulated by ATP turnover. The interplay of peripheral and
mitochondrial creatine kinases (Fig. 5A) translates the ATP
turnover into varying creatine level. Thus, high ATP turnover
through creatine kinase suppresses Ca2+-dependent Ca2+
release although the intramitochondrial Ca2+ is high. In
addition, high ATP turnover and stimulation of oxidative
phosphorylation by mitochondrial creatine kinase decreases
ROS generation that is a well known factor for regulating the
permeability transition pore [106,112]. High intramitochondrial
ATP turnover (supported by the mitochondrial respiration rate)
was found to be directly related to creatine concentration [23].
This and the activity of creatine kinases provide the basis for
the energy reserve in the heart [1,25,89] (the ability of the heart
to increase cardiac performance on demand) through increasing
the number of complexes between mitochondrial creatine
kinase and ANT also inside the mitochondria along the cristae
[94].
By interacting with the regulatory proteins, ANT thus
becomes an integral point over substrate supply through
hexokinase, ATP turnover through creatine kinase, and Ca2+
level through cyclophilin. As schematically depicted in Fig. 5,
hormonal control engages the ANT regulatory proteins to
adjust the energy supply. This has also an impact on apoptosis
regulation as well. Thus, growth factors through protein kinase
B and increasing hexokinase binding suppress apoptosis,
whereas epinephrine through c-AMP protein kinase A and
decreasing of hexokinase binding promote apoptosis. Similarly,
activated AMP kinase by inducing fatty acid oxidation (in the
late phase) and glycolysis through increased hexokinase
binding (in the early phase) in its turn suppresses apoptosis.
The same regulatory mechanisms apply for Bax-dependent
release of mitochondrial cytochrome c. The latter is organised
in the VDAC–ANT complex (Fig. 2A, C, D) that is a binding
target, which hexokinase and Bax are competing for. Thus,
regulators that support hexokinase binding to the complex such
as PKB and AMPK will suppress cytochrome c release while
systems inducing Bax binding such as p53 will facilitate
cytochrome c release (Fig. 2).
In some disorders where defects in mitochondrial bioener-
getics are detected a protective effect of creatine supplemen-
tation has been observed such as Duchenne muscular
dystrophy [113–115], mitochondrial cytopathies [116], and in
animal models of amyotrophic lateral sclerosis [117–119],
Huntington’s disease [120,121], Parkinsonism [122], as well as
in brain ischemia [123,124]. However, this field is still
controversial and there are some reported cases where creatine
supplementation had no benefit for the patients [125] So far
clinical investigations studying creatine supplementation in a
large number of patients are missing and it is therefore too
early to draw final conclusions about the clinical application of
creatine. However, the crucial role of mitochondrial contact
sites in regulating cellular bioenergetics, Ca2+ homeostasis,
ROS generation, and apoptosis will definitely draw more future
work to this exciting research topic.
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